Literature DB >> 2642270

Inhibition of 'in vitro' tumor cell growth by aromatic polyamidines exhibiting antiproteinase activity.

C Nastruzzi1, G Feriotto, D Spandidos, R Ferroni, M Guarneri, R Barbieri, R Gambari.   

Abstract

Aromatic polyamidines containing two, three or four benzamidine residues inhibit proteinase activity and proliferation of different human tumor cell lines, including leukemic (K562, HEL), melanoma (Colo 38) and B-lymphoid (WI-L2) cell lines. In addition, the benzamidine derivatives analysed in the present study inhibit cell growth of the Chinese hamster FHO6T1-1 cell line, obtained after transfection of primary lung cells with the activated human T24-Ha-ras-1 oncogene. After treatment of FHO6T1-1 cells with benzamidine derivatives, a sharp decrease of the content of Ha-ras-1 mRNA was found, but not of transferrin receptor mRNA. We found that inhibition of cell proliferation by tetra-benzamidine derivatives is not restricted to tumor cells, but concerns also non-tumorigenic cell lines as well as normal primary fibroblasts. Therefore, our analysis was extended to di- and tri-benzamidine derivatives, which could be proposed as useful substrates in the synthesis of drug-conjugated monoclonal antibodies or growth factors. The data obtained demonstrate that these latter compounds and their halo-derivatives also exhibit strong antiproliferative effects on in vitro cultured cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2642270     DOI: 10.1007/bf02057179

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  41 in total

1.  C-myc expression is reduced in antipain-treated proliferating C3H 10T1/2 cells.

Authors:  J D Chang; P C Billings; A R Kennedy
Journal:  Biochem Biophys Res Commun       Date:  1985-12-17       Impact factor: 3.575

2.  Differential effects of benzamidine derivatives on the expression of c-myc and HLA-DR alpha genes in a human B-lymphoid tumor cell line.

Authors:  C Nastruzzi; G Feriotto; R Barbieri; R Ferroni; M Guarneri; R Gambari
Journal:  Cancer Lett       Date:  1988-01       Impact factor: 8.679

3.  The complete primary structure of protein kinase C--the major phorbol ester receptor.

Authors:  P J Parker; L Coussens; N Totty; L Rhee; S Young; E Chen; S Stabel; M D Waterfield; A Ullrich
Journal:  Science       Date:  1986-08-22       Impact factor: 47.728

Review 4.  Cancer metastasis. Organ colonization and the cell-surface properties of malignant cells.

Authors:  G L Nicolson
Journal:  Biochim Biophys Acta       Date:  1982-12-21

5.  Protease inhibitors as anticarcinogens.

Authors:  W Troll; K Frenkel; R Wiesner
Journal:  J Natl Cancer Inst       Date:  1984-12       Impact factor: 13.506

6.  Characterization of the procollagen IV cleavage products produced by a specific tumor collagenase.

Authors:  L I Fessler; K G Duncan; J H Fessler; T Salo; K Tryggvason
Journal:  J Biol Chem       Date:  1984-08-10       Impact factor: 5.157

Review 7.  The pathogenesis of cancer metastasis.

Authors:  G Poste; I J Fidler
Journal:  Nature       Date:  1980-01-10       Impact factor: 49.962

8.  Primary structure of human transferrin receptor deduced from the mRNA sequence.

Authors:  C Schneider; M J Owen; D Banville; J G Williams
Journal:  Nature       Date:  1984 Oct 18-24       Impact factor: 49.962

9.  Bowman-Birk soybean protease inhibitor as an anticarcinogen.

Authors:  J Yavelow; T H Finlay; A R Kennedy; W Troll
Journal:  Cancer Res       Date:  1983-05       Impact factor: 12.701

10.  Studies of methotrexate-monoclonal antibody conjugates for immunotherapy.

Authors:  J Kanellos; G A Pietersz; I F McKenzie
Journal:  J Natl Cancer Inst       Date:  1985-08       Impact factor: 13.506

View more
  1 in total

1.  Liposome mediated delivery of retinoids and aromatic polyamidines: Effects on growth of tumor cell lines.

Authors:  C Nastruzzi; G Feriotto; P Walde; E Menegatti; R Gambari
Journal:  Cytotechnology       Date:  1991-02       Impact factor: 2.058

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.